These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9568638)

  • 81. Deregulated expression of urokinase and its inhibitor type 1 in prostate cancer cells: role of epigenetic mechanisms.
    Hagelgans A; Menschikowski M; Fuessel S; Nacke B; Arneth BM; Wirth MP; Siegert G
    Exp Mol Pathol; 2013 Jun; 94(3):458-65. PubMed ID: 23541763
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator.
    Shi C; Zhang N; Feng Y; Cao J; Chen X; Liu B
    Cell Physiol Biochem; 2017; 41(4):1313-1324. PubMed ID: 28278500
    [TBL] [Abstract][Full Text] [Related]  

  • 83. PTHrP [67-86] regulates the expression of stress proteins in breast cancer cells inducing modifications in urokinase-plasminogen activator and MMP-1 expression.
    Luparello C; Sirchia R; Pupello D
    J Cell Sci; 2003 Jun; 116(Pt 12):2421-30. PubMed ID: 12724357
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Inhibition of matrix metalloproteinase-9 expression by docosahexaenoic acid mediated by heme oxygenase 1 in 12-O-tetradecanoylphorbol-13-acetate-induced MCF-7 human breast cancer cells.
    Chen HW; Chao CY; Lin LL; Lu CY; Liu KL; Lii CK; Li CC
    Arch Toxicol; 2013 May; 87(5):857-69. PubMed ID: 23288142
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Retinoic acid-enhanced invasion through reconstituted basement membrane by human SK-N-SH neuroblastoma cells involves membrane-associated tissue-type plasminogen activator.
    Tiberio A; Farina AR; Tacconelli A; Cappabianca L; Gulino A; Mackay AR
    Int J Cancer; 1997 Nov; 73(5):740-8. PubMed ID: 9398056
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Invasiveness corresponds to differentiation rather than to proteinase secretion in endometrial cancer cell lines.
    Sillem M; Prifti S; Koumouridis A; Runnebaum B
    Eur J Gynaecol Oncol; 1999; 20(5-6):367-70. PubMed ID: 10609496
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Loss of the metastatic phenotype by a human epidermoid carcinoma cell line, HEp-3, is accompanied by increased expression of tissue inhibitor of metalloproteinase 2.
    Testa JE
    Cancer Res; 1992 Oct; 52(20):5597-603. PubMed ID: 1327511
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP.
    Hamasuna R; Kataoka H; Moriyama T; Itoh H; Seiki M; Koono M
    Int J Cancer; 1999 Jul; 82(2):274-81. PubMed ID: 10389763
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Breast cancer cell invasiveness: correlation with protein kinase C activity and differential regulation by phorbol ester in estrogen receptor-positive and -negative cells.
    Platet N; Prévostel C; Derocq D; Joubert D; Rochefort H; Garcia M
    Int J Cancer; 1998 Mar; 75(5):750-6. PubMed ID: 9495244
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cyclooxygenase-2 uses the protein kinase C/ interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cells.
    Simeone AM; Nieves-Alicea R; McMurtry VC; Colella S; Krahe R; Tari AM
    Int J Oncol; 2007 Apr; 30(4):785-92. PubMed ID: 17332916
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro.
    Balduyck M; Zerimech F; Gouyer V; Lemaire R; Hemon B; Grard G; Thiebaut C; Lemaire V; Dacquembronne E; Duhem T; Lebrun A; Dejonghe MJ; Huet G
    Clin Exp Metastasis; 2000; 18(2):171-8. PubMed ID: 11235993
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Molecular mechanism depressing PMA-induced invasive behaviors in human lung adenocarcinoma cells by cis- and trans-cinnamic acid.
    Tsai CM; Sun FM; Chen YL; Hsu CL; Yen GC; Weng CJ
    Eur J Pharm Sci; 2013 Feb; 48(3):494-501. PubMed ID: 23228413
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Expression of MMPs and TIMPs genes in human breast cancer epithelial cells depends on cell culture conditions and is associated with their invasive potential.
    Kousidou OC; Roussidis AE; Theocharis AD; Karamanos NK
    Anticancer Res; 2004; 24(6):4025-30. PubMed ID: 15739263
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Inhibition of TPA‑induced metastatic potential by morin hydrate in MCF‑7 human breast cancer cells via the Akt/GSK‑3β/c‑Fos signaling pathway.
    Lee KS; Nam GS; Baek J; Kim S; Nam KS
    Int J Oncol; 2020 Feb; 56(2):630-640. PubMed ID: 31939617
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Enhancement of type IV collagenases by highly metastatic variants of HT1080 fibrosarcoma cells established by a transendothelial invasion system in vitro.
    Okada T; Li J; Kodaka M; Okuno H
    Clin Exp Metastasis; 1998 Apr; 16(3):267-74. PubMed ID: 9568644
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Fibroblasts surrounding melanoma express elevated levels of matrix metalloproteinase-1 (MMP-1) and intercellular adhesion molecule-1 (ICAM-1) in vitro.
    Wandel E; Grasshoff A; Mittag M; Haustein UF; Saalbach A
    Exp Dermatol; 2000 Feb; 9(1):34-41. PubMed ID: 10688373
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Targeting of the β6 gene to suppress degradation of ECM via inactivation of the MAPK pathway in breast adenocarcinoma cells.
    Zhang Y; Wei L; Yu J; Li G; Zhang X; Wang A; He Y; Li H; Yin D
    Oncol Rep; 2014 Nov; 32(5):1787-95. PubMed ID: 25176506
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effect of progesterone on the invasive properties and tumor growth of progesterone receptor-transfected breast cancer cells MDA-MB-231.
    Lin VC; Eng AS; Hen NE; Ng EH; Chowdhury SH
    Clin Cancer Res; 2001 Sep; 7(9):2880-6. PubMed ID: 11555606
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Ovarian cancer cell invasion is inhibited by paclitaxel.
    Westerlund A; Hujanen E; Höyhtyä M; Puistola U; Turpeenniemi-Hujanen T
    Clin Exp Metastasis; 1997 May; 15(3):318-28. PubMed ID: 9174131
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4.
    Byon CH; Hardy RW; Ren C; Ponnazhagan S; Welch DR; McDonald JM; Chen Y
    Lab Invest; 2009 Nov; 89(11):1221-8. PubMed ID: 19752858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.